SEC Info - Regional Health Properties, Inc. - ‘10-Q’ for 6/30/22

SEC Info℠

Home

My Interests

Help

Please Sign In

Regional Health Properties, Inc. – ‘10-Q’ for 6/30/22 – ‘EX-31.1’

On: Tuesday, 8/23/22, at 4:56pm ET · For: 6/30/22 · Accession #: 950170-22-17694 · File #: 1-33135

Previous ‘10-Q’: ‘10-Q’ on 5/31/22 for 3/31/22 · Next: ‘10-Q’ on 11/22/22 for 9/30/22 · Latest: ‘10-Q’ on 11/14/23 for 9/30/23 · 14 References:

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/23/22  Regional Health Properties, Inc.  10-Q        6/30/22   82:15M                                    Donnelley … Solutions/FA

Quarterly Report — Form 10-Q

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   3.96M 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     29K 
 3: EX-31.2     Certification -- §302 - SOA'02                      HTML     29K 
 4: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 5: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
11: R1          Document and Entity Information                     HTML     82K 
12: R2          Consolidated Balance Sheets                         HTML    109K 
13: R3          Consolidated Balance Sheets (Parenthetical)         HTML     46K 
14: R4          Consolidated Statements of Operations               HTML    122K 
15: R5          Consolidated Statements of Stockholders' Equity     HTML     92K 
16: R6          Consolidated Statements of Cash Flows (Unaudited)   HTML     95K 
17: R7          Organization and Significant Accounting Policies    HTML    207K 
18: R8          Liquidity                                           HTML     84K 
19: R9          Cash and Restricted Cash                            HTML     71K 
20: R10         Property and Equipment                              HTML    102K 
21: R11         Intangible Assets and Goodwill                      HTML    184K 
22: R12         Leases                                              HTML    128K 
23: R13         Accrued Expenses                                    HTML     63K 
24: R14         Notes Payable and Other Debt                        HTML    396K 
25: R15         Common and Preferred Stock                          HTML     40K 
26: R16         Stock Based Compensation                            HTML    185K 
27: R17         Commitments and Contingencies                       HTML     47K 
28: R18         Segments Results                                    HTML    395K 
29: R19         Subsequent Events                                   HTML     29K 
30: R20         Organization and Significant Accounting Policies    HTML    238K 
                (Policies)                                                       
31: R21         Organization and Significant Accounting Policies    HTML    112K 
                (Tables)                                                         
32: R22         Cash and Restricted Cash (Tables)                   HTML     65K 
33: R23         Property and Equipment (Tables)                     HTML    101K 
34: R24         Intangible Assets and Goodwill (Tables)             HTML    187K 
35: R25         Leases (Tables)                                     HTML     98K 
36: R26         Accrued Expenses (Tables)                           HTML     57K 
37: R27         Notes Payable and Other Debt (Tables)               HTML    388K 
38: R28         Stock Based Compensation (Tables)                   HTML    175K 
39: R29         Segments Results (Tables)                           HTML    385K 
40: R30         Organization and Significant Accounting Policies -  HTML    129K 
                Additional Information (Details)                                 
41: R31         Organization and Significant Accounting Policies -  HTML     36K 
                Company's Accounts Receivable, Net of Allowance                  
                (Details)                                                        
42: R32         Organization and Significant Accounting Policies -  HTML     30K 
                Company's Accounts Payable (Details)                             
43: R33         Organization and Significant Accounting Policies -  HTML     33K 
                Anti-dilutive Securities (Details)                               
44: R34         Liquidity - Additional Information (Details)        HTML    239K 
45: R35         Cash and Restricted Cash - Schedule of Cash and     HTML     46K 
                Restricted Cash (Details)                                        
46: R36         Cash and Restricted Cash - Schedule of Cash and     HTML     28K 
                Restricted Cash (Parenthetical) (Details)                        
47: R37         Property and Equipment - Schedule of Property and   HTML     46K 
                Equipment (Details)                                              
48: R38         Property and Equipment - Schedule of Property and   HTML     29K 
                Equipment (Parenthetical) (Details)                              
49: R39         Property and Equipment - Schedule of Total          HTML     31K 
                Depreciation and Amortization Expense of Property                
                and Equipment (Details)                                          
50: R40         Intangible Assets and Goodwill - Schedule of        HTML     57K 
                Intangible Assets and Goodwill (Details)                         
51: R41         Intangible Assets and Goodwill - Schedule of Total  HTML     33K 
                Amortization Expense (Details)                                   
52: R42         Intangible Assets and Goodwill - Schedule of        HTML     45K 
                Estimated Amortization Expense for All Definite                  
                Lived Intangibles (Details)                                      
53: R43         Leases - Operating Leases - Additional Information  HTML     33K 
                (Details)                                                        
54: R44         Leases - Schedule of Future Minimum Lease Payments  HTML     69K 
                (Details)                                                        
55: R45         Leases - Schedule of Future Minimum Lease Payments  HTML     25K 
                (Parenthetical) (Details)                                        
56: R46         Leases - Sublease Termination - Additional          HTML     37K 
                Information (Details)                                            
57: R47         Leases - Facilities Lessor - Additional             HTML     33K 
                Information (Details)                                            
58: R48         Leases - Schedule of Future Minimum Lease           HTML     39K 
                Receivables from Company's Facilities Leased and                 
                Subleased to Third Party Tenants (Details)                       
59: R49         Leases - Recent Events - Additional Information     HTML     74K 
                (Details)                                                        
60: R50         Accrued Expenses - Schedule of Accrued Expenses     HTML     44K 
                (Details)                                                        
61: R51         Accrued Expenses - Schedule of Accrued Expenses     HTML     28K 
                (Parenthetical) (Details)                                        
62: R52         Notes Payable and Other Debt - Summary of Debt      HTML     45K 
                (Details)                                                        
63: R53         Notes Payable and Other Debt - Details of           HTML    109K 
                Long-term Debt (Details)                                         
64: R54         Notes Payable and Other Debt - Details of           HTML     76K 
                Long-term Debt (Parenthetical) (Details)                         
65: R55         Notes Payable and Other Debt - Additional           HTML     25K 
                Information (Details)                                            
66: R56         Notes Payable and Other Debt - Summary of the       HTML     48K 
                Scheduled Maturities (Details)                                   
67: R57         Common and Preferred Stock - Additional             HTML     67K 
                Information (Details)                                            
68: R58         Stock Based Compensation - Additional Information   HTML     61K 
                (Details)                                                        
69: R59         Stock Based Compensation - Summary of Recognized    HTML     34K 
                Stock Based Compensation (Details)                               
70: R60         Stock Based Compensation - Summary of Company's     HTML     48K 
                Restricted Stock Activity (Details)                              
71: R61         Stock Based Compensation - Summary of Company's     HTML     54K 
                Stock Option Activity (Details)                                  
72: R62         Stock Based Compensation - Schedule of Exercise     HTML     40K 
                Price Range (Details)                                            
73: R63         Stock Based Compensation - Schedule of Exercise     HTML     29K 
                Price Range (Parenthetical) (Details)                            
74: R64         Commitments and Contingencies - Additional          HTML     46K 
                Information (Details)                                            
75: R65         Segment Results - Additional Information (Details)  HTML     43K 
76: R66         Segment Results - Summary of Results of Operations  HTML    115K 
                for Reporting Segments (Details)                                 
77: R67         Subsequent Events - Additional Information          HTML     50K 
                (Details)                                                        
80: XML         IDEA XML File -- Filing Summary                      XML    152K 
78: XML         XBRL Instance -- rhe-20220630_htm                    XML   4.38M 
79: EXCEL       IDEA Workbook of Financial Reports                  XLSX    192K 
 9: EX-101.CAL  XBRL Calculations -- rhe-20220630_cal                XML    188K 
 8: EX-101.DEF  XBRL Definitions -- rhe-20220630_def                 XML   1.05M 
 7: EX-101.LAB  XBRL Labels -- rhe-20220630_lab                      XML   1.65M 
10: EX-101.PRE  XBRL Presentations -- rhe-20220630_pre               XML   1.31M 
 6: EX-101.SCH  XBRL Schema -- rhe-20220630                          XSD    250K 
81: JSON        XBRL Instance as JSON Data -- MetaLinks              443±   733K 
82: ZIP         XBRL Zipped Folder -- 0000950170-22-017694-xbrl      Zip    440K

‘EX-31.1’ — Certification — §302 – SOA’02

This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Brent Morrison, certify that:

I have reviewed this quarterly report on Form 10-Q of Regional Health Properties, Inc.;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


August 23, 2022	By	/s/ *Brent Morrison*
		Chief Executive Officer and President

Dates Referenced Herein and Documents Incorporated by Reference

This ‘10-Q’ Filing	Date	Other Filings

Filed on:	8/23/22
For Period end:	6/30/22	NT 10-Q
		List all Filings

14 Previous Filings that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/12/21  Regional Health Properties, Inc.  10-Q        9/30/21   87:15M                                    ActiveDisclosure/FA
 9/27/21  Regional Health Properties, Inc.  8-K:1,9     9/21/21   12:365K                                   ActiveDisclosure/FA
 7/02/21  Regional Health Properties, Inc.  S-4/A                  6:10M                                    ActiveDisclosure/FA
 5/14/21  Regional Health Properties, Inc.  10-Q        3/31/21   83:10M                                    ActiveDisclosure/FA
 3/29/21  Regional Health Properties, Inc.  10-K       12/31/20  106:18M                                    ActiveDisclosure/FA
 1/07/21  Regional Health Properties, Inc.  8-K:1,9     1/01/21    3:806K                                   ActiveDisclosure/FA
12/17/20  Regional Health Properties, Inc.  8-K:5,9    12/16/20    2:203K                                   ActiveDisclosure/FA
 5/17/19  Regional Health Properties, Inc.  10-K       12/31/18  128:26M                                    ActiveDisclosure/FA
12/28/18  Regional Health Properties, Inc.  8-K:5,8,9  12/27/18    3:201K                                   ActiveDisclosure/FA
10/02/17  Regional Health Properties, Inc.  8-K12B:2,3, 9/29/17    8:2.2M
 7/08/13  Regional Health Properties, Inc.  10-K       12/31/12  229:37M                                    Toppan Merrill-FA
10/27/11  Regional Health Properties, Inc.  S-8        10/27/11    9:445K                                   Toppan Merrill/FA
 7/14/11  Regional Health Properties, Inc.  S-3                    7:2.1M                                   Toppan Merrill/FA
 3/31/08  Regional Health Properties, Inc.  10KSB      12/31/07    9:8.2M

↑Top

Filing Submission 0000950170-22-017694 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)